INTERNATIONAL PATENT: BAYER AKTIENGESELLSCHAFT FILES APPLICATION FOR "FINERENONE FOR USE IN A METHOD OF PREVENTING OR TREATING HEART FAILURE IN A PATIENT RECEIVING A CYP3A4 INHIBITOR OR A CYP3A4 INDUCER"

GENEVA, July 14 -- BAYER AKTIENGESELLSCHAFT (Kaiser-Wilhelm-Allee 151373 Leverkusen) filed a patent application (PCT/EP2025/050103) for "FINERENONE FOR USE IN A METHOD OF PREVENTING OR TREATING HEART FAILURE IN A PATIENT RECEIVING A CYP3A4 INHIBITOR OR A CYP3A4 INDUCER" on Jan 03, 2025. With publication no. WO/2025/146482, the details related to the patent application was published on Jul 10, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KOLKHOF, Peter (Falkenberg 12142113 Wuppertal), SCHLOMER, Patrick (Tapiauer StraBe 1827211 Bassum), FRITSCH, Arno (Am Kasinogarten 942105 Wuppertal), BOMF...